Nizar El-Murr

809 citations
9 papers · 246 indexed · h-index 7
Topics
Multiple Myeloma Research and Treatments (4 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)Glycosylation and Glycoproteins Research (2 papers)
Partner nations
FranceUnited StatesJapan

In The Last Decade

Nizar El-Murr

9 papers receiving 244 citations

Peers

Nizar El-Murr
Comparison fields: 5 of 43
  • Molecular Biology 146
  • Oncology 120
  • Cancer Research 74
  • Genetics 39
  • Cell Biology 33
Replace Christine von Klitzing with:
Christine von Klitzing Germany
Valentina Agnusdei Italy
Leenus Martin United States
Matthew J. Simmons United States
C Ludwig United States
Kuen‐Tyng Lin Taiwan
Binh Phong United States
Eric Kusnadi Australia
Jin Woo Park South Korea
Juri Na South Korea
Nizar El-Murr relative to Christine von Klitzing Germany Christine von Klitzing's profile →
Citations per field
00.5×1.5×2.5×
Christine von Klitzing · 1×
Citations per year

Countries citing papers authored by Nizar El-Murr

Since Specialization
Citations

This map shows the geographic impact of Nizar El-Murr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nizar El-Murr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nizar El-Murr more than expected).

Fields of papers citing papers by Nizar El-Murr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nizar El-Murr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nizar El-Murr. The network helps show where Nizar El-Murr may publish in the future.

Co-authorship network of co-authors of Nizar El-Murr

This figure shows the co-authorship network connecting the top 25 collaborators of Nizar El-Murr. A scholar is included among the top collaborators of Nizar El-Murr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nizar El-Murr. Nizar El-Murr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 17
2 8
3 1
4 8
5 4
6 49
7 109
8 14
9 36

About Nizar El-Murr

Nizar El-Murr is a scholar working on Hematology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 246 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Cancer Research (74 citations), Oncology (120 citations) and Molecular Biology (146 citations). Nizar El-Murr has collaborated with scholars based in France, United States and Japan. Frequent co-authors include Jörg Tost, Samia Mourah, Alexandre How‐Kit, Sarah Guégan, Thécla Lesuffleur, R Fontaine, Gabriel G. Malouf, Arnaud Picard, Natacha Kadlub and Alex Duval. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026